SOURCE: Medical Nutrition USA, Inc.

Medical Nutrition USA, Inc.

April 29, 2009 13:45 ET

Medical Nutrition USA Introduces New Pro-Stat® AWC With Citrulline for Increased Effectiveness in Wound Care

ENGLEWOOD, NJ--(Marketwire - April 29, 2009) - Medical Nutrition USA, Inc. (NASDAQ: MDNU), a developer and distributor of proprietary, nutrition medicine products, announced the introduction of Pro-Stat® AWC with Citrulline. The product, which is an enhanced formulation of Pro-Stat® AWC, is designed for patients in long-term care facilities with advanced wounds, primarily pressure ulcers.

Pressure ulcers, also know as bedsores, can significantly diminish quality of life and require substantial cost to remedy. Also, statistics show the incidence of bedsores to be as high as one-in-four among long-term care residents, with a price tag for treatment of $1.3 billion nationally.

Pro-Stat® AWC with Citrulline is the only wound care supplement with Citrulline, an amino acid that safely and effectively increases Arginine levels to produce nitric oxide needed for wound healing. Nitric oxide is used by the inner lining of blood vessels to relax the surrounding smooth muscle, resulting in a widening of blood vessels and increased blood flow to the wound.

A clinical study, conducted by S. Kwon Lee MD, FACS, and published in the journal Advances in Skin & Wound Care in 2006, of long-term care residents with pressure ulcers showed a 96% improvement in healing rates among those residents that received standard care plus Pro-Stat® compared to a control group that received standard care plus a placebo.

"Pro-Stat® AWC with Citrulline is an even more effective treatment option for patients with pressure ulcers," said Frank A. Newman, Medical Nutrition USA's Chairman and Chief Executive Officer. "This important addition to the Pro-Stat® product line demonstrates Medical Nutrition USA's continuing dedication to developing significant and highly-effective new products on a timely basis."

About Medical Nutrition USA, Inc.

Medical Nutrition USA, Inc. (NASDAQ: MDNU), is a growing supplier of a line of engineered and clinically tested medical nutritional supplements aimed primarily at nursing homes, assisted living communities and dialysis markets nationwide. The company's strong performance is the result of its significant and growing share in U.S. and Canadian institutional markets that is accelerated by ongoing, successful new-product development and introductions. Find more on Medical Nutrition at www.mdnu.com.

This press release contains forward-looking statements that are subject to certain risks and uncertainties. Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed. Risks and uncertainties that could cause or contribute to such material difference include, but are not limited to, general economic conditions, changes in customer demand, changes in trends in the nursing home, renal care, health food and bariatric surgery markets, changes in competitive pricing for products, and the impact of our competitors' new product introductions. Our future financial condition and results of operations, as well as any forward-looking statements are subject to change and inherent risk and uncertainties. Other important factors that may cause actual results to differ materially from those expressed in forward-looking statements is contained in the Medical Nutrition USA, Inc. Annual Report on Form 10-K for the year ended January 31, 2009 as filed with the Securities and Exchange Commission on April 24, 2009.

Contact Information

  • Contacts:
    Medical Nutrition USA, Inc.
    Frank J. Kimmerling
    Vice President/CFO
    800.221.0308
    Email Contact

    Investor Relations
    Adam Friedman
    212.981.2529 x18
    Email Contact